Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
YTHDC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CRYZ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PDGFC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OXCT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MSI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EFEMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NBPF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TBL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DSG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUSC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARVA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP55 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00938 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKAR2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YWHAQ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRMT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on